erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
.
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.
sheffield’s music in the gardens to support local charities
.